TLR6 and metabolic dysfunction-associated steatohepatitis: TLR6 expression in B cells, T cells and monocytes was found significantly higher in patients with NASH, compared to those with normal liver biopsies or NAFL, which can reflect the potential of this receptor as a peripheral biomarker of obesity-related NASH.